Fermenta Biotech Limited (BOM:506414)
315.55
-3.45 (-1.08%)
At close: Mar 4, 2026
Fermenta Biotech Market Cap
Fermenta Biotech has a market cap or net worth of 9.56 billion as of March 5, 2026. Its market cap has decreased by -2.62% in one year.
Market Cap
9.56B
Enterprise Value
10.11B
Revenue
5.44B
Ranking
n/a
PE Ratio
10.99
Stock Price
315.55
Market Cap Chart
Since July 31, 1998, Fermenta Biotech's market cap has increased from 335.80M to 9.56B, an increase of 2,746.26%. That is a compound annual growth rate of 12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 9.29B | -9.32% |
| Dec 31, 2025 | 10.24B | -4.38% |
| Dec 31, 2024 | 10.71B | 129.56% |
| Dec 29, 2023 | 4.67B | -6.88% |
| Dec 30, 2022 | 5.01B | -40.13% |
| Dec 31, 2021 | 8.37B | -8.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kwality Pharmaceuticals | 16.14B |
| TTK Healthcare | 12.91B |
| Lincoln Pharmaceuticals | 12.77B |
| Syncom Formulations (India) | 12.00B |
| Wanbury | 9.29B |
| Venus Remedies | 8.98B |
| Bharat Parenterals | 7.87B |
| Anuh Pharma | 7.76B |